Control of glycolysis in cultured chick embryo hepatocytes. Fructose 2,6-bisphosphate content and phosphofructokinase-1 activity are stimulated by insulin and epidermal growth factor.
Chick embryo hepatocytes were maintained in monolayer culture in a serum-free chemically defined medium for periods of up to 2 days. Over this time period, insulin provoked selective increases (up to 5-fold) in factors relevant to the control of glycolysis: the activities of phosphofructokinase-1 (PFK-1), phosphofructokinase-2 (PFK-2) and hexokinase isoenzymes and the content of fructose 2,6-bisphosphate (F26BP). Half-maximal effects of insulin on pFK-1 activity were in the physiological range (0.1 nM). Changes in enzyme activities and F26BP content in response to insulin were correlated with stimulation of glycolytic flux as estimated by radioisotopic flux. These data are discussed in relation to known changes which occur in hepatic glycolytic activity and PFK-1 activity in the intact chick around hatching. The effects of insulin on F26BP content, PFK-1 activity and glycolytic flux were mimicked by epidermal growth factor (EGF). In contrast, phorbol esters produced minimal actions on any of the above parameters. Our data indicate that protein kinase C is not involved in the actions of insulin or EGF in control of F26BP content or PFK-1 activity. This work indicates that the related tyrosyl kinase receptors of insulin and EGF may provoke identical responses within hepatocytes, but through the utilization of different transduction systems which merge to common control points.
Hamer
M J
MJ
Department of Biochemistry and Molecular Biology, University of Manchester, U.K.
Dickson
A J
AJ
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000502:physiology; D005635:Fructosediphosphates / Q000378:metabolism; D006019:Glycolysis / Q000502:physiology*; D007328:Insulin / Q000502:physiology; D008099:Liver / Q000166:cytology / Q000196:embryology / Q000201:enzymology / Q000378:metabolism*; D010703:Phorbol Esters / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000378:metabolism
D005635:Fructosediphosphates; D007328:Insulin; D010703:Phorbol Esters; D004815:Epidermal Growth Factor; C027652:fructose 2,6-diphosphate; D010732:Phosphofructokinase-1